Navigation Links
Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Date:5/21/2009

ience," OAB is disabling and associated with a marked decrease in health-related quality of life as well as higher rates of depression. The disease affects both men and women however, women experience more severe symptoms earlier in life.

In addition to GELNIQUE, Watson recently launched RAPAFLO(TM) (silodosin), the Company's new alpha blocker for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), which offers rapid relief and has an exceptional safety profile. The Company also has submitted a New Drug Application for its 6-month formulation of TRELSTAR(R) (triptorelin pamoate), a luteinizing hormone releasing hormone (LHRH) agonist for the palliative treatment of advanced prostate cancer. Watson anticipates that FDA will take action on this application in the third quarter 2009.

About GELNIQUE

GELNIQUE is a quick-drying, clear and colorless, fragrance-free hydroalcoholic gel containing oxybutynin chloride, an antispasmodic antimuscarinic agent. Applied once daily to the thigh, abdomen, upper arm or shoulder, one-gram (approx. 1 mL) of GELNIQUE gel 10% delivers a consistent dose of oxybutynin through the skin over a 24-hour period, providing strong efficacy with excellent tolerability.

Because the active ingredient in GELNIQUE is delivered transdermally, it is not metabolized in the same way as orally administered oxybutynin. It bypasses fist-pass metabolism, which reduces the formation of the N-desethyloxybutynin metabolite (N-DEO), which may be linked to unwanted side effects such as dry mouth and constipation. In clinical trials, GELNIQUE users reported low levels of dry mouth (6.9%) and constipation (1.3%).

In a Phase 3, 12-week trial, one-gram, once-daily GELNIQUE was superior to placebo at relieving OAB symptoms, including a reduction in incontinence episodes and urinary frequency, and an increase in urine void volume. The treatment
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4

Related medicine news :

1. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
2. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
3. Watson Files FDA Applications for Generic Mucinex(R)
4. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
5. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
6. Mark G. Watson Named Executive Director of Radiological Society of North America
7. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
8. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
9. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
10. Warner Chilcott and Watson Pharmaceuticals Announce Agreements on Loestrin(R) 24 and Femcon(R) Fe Patent Litigation
11. Watson Pharmaceuticals Receives FDA Approval for Mint Coated Nicotine Gum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Kayentis, the global leader of Digital Pen and Paper technology ... for clinical trials, today announced that it is ranked among ... 500 - EMEA 2009. , ... ... integrated software solutions for the capture, digitalization and management of ...
(Date:12/16/2009)... marketing campaign , ... Englewood, CO ... Genetown™ Hotbed Campaign as its largest yearly promotion for ... MassBio and showcases 37 Massachusetts companies across biotechnology, ... brand on an electronic and printed map that ...
(Date:12/16/2009)... uninsured, government report finds , , WEDNESDAY, Dec. 16 (HealthDay ... year, 45.4 million Americans of all ages -- or ... insurance, according to new National Health Interview Survey statistics ... people of all ages had been uninsured for at ... and 31.9 million (10.6 percent) had been uninsured for ...
(Date:12/16/2009)... -- Shoppers like knowing if their salad is ... grocers have found it burdensome to implement the ... them to provide the information at point of ... for easily making grocery and produce signs ... require retailers of unprocessed fruits, vegetables and other ...
(Date:12/16/2009)... Medical travel facilitator Companion Global Healthcare ... Rico into its network of international hospitals that ... those at mainland U.S. facilities. ,, The announcement ... assistance and preferred pricing for its individual clients ... either HIMA San Pablo Bayamon or HIMA San ...
Breaking Medicine News(10 mins):Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:Over 45 Million Americans Now Lack Health Insurance 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2
... associated with any biological or adverse health effects, according ... risks from mobile telephone technology. , The Mobile Telecommunications ... September 12 as part of its 2007 Report. , ... Emeritus Professor of Physics at The University of Nottingham, ...
... Pink Savings Cards Give Tanger Shoppers the Chance to Help ... Saving Money on Their Purchases, GREENSBORO, N.C., Sept. 12 ... at Tanger Outlet Centers. Tanger is celebrating its,14th anniversary in ... Shoppers can join Tanger in its effort to save lives ...
... to the Public, ATLANTA, Sept. 12 ... investment company is about to launch a new ... will bring,professional-grade physical therapy and sports rehabilitation services ... http://www.newscom.com/cgi-bin/prnh/20070912/DCW010LOGO ) AMB Group, LLC, today ...
... Inc., a,pioneer in health and condition (disease) management, ... Synergy Personal Health,Management program at DMAA,s Disease Management ... at Caesar,s Palace in Las,Vegas. With the ... to stay,informed of the best practices, latest technologies ...
... Liberty State Park to celebrate and press for ... JERSEY CITY, N.J., Sept. 12 , What: The joint New Jersey/New York ... centerpiece of more than 50 celebratory and advocacy ... of Americans who are in long-term recovery from addiction to ...
... grant and an Ontario Early Researcher Award, Prof. Yu ... http://amnl.mie.utoronto.ca ) at the University of Toronto (U of ... of zebrafish embryos. , Based on computer vision ... of immobilizing a large number of zebrafish embryos into ...
Other Medicine News:Health News:New report on mobile phone research published 2Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 2Health News:Atlanta Falcons Physical Therapy Centers Set to Launch This Fall 3Health News:Health Integrated to Showcase Synergy Personal Health Management(R) at DMAA Conference 2
(Date:12/16/2009)... AMSTERDAM, December 16 Today, Avantium ... Executive Officer of its pharmaceutical,business. Gunnar Staaf ... and Eli Lilly & Company, in a ... is an important step in Avantium,s plan ... to create a,stand-alone pharmaceutical company based on ...
(Date:12/16/2009)... Senate Vote Against Lower Prescription Drug Prices ... Senate on Tuesday night rejected an amendment to ... would help make prescription drugs more affordable by ... lower priced drugs from abroad. The bipartisan ... Dorgan, Snowe, McCain, Grassley and Stabenow, would have ...
(Date:12/16/2009)... Calif., Dec. 16 Frost & ... Bujnoch, looks forward to speaking at the ... taking place on January 9, 2010 in ... the emerging market of consumer-based digital health ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) ,, Bujnoch ...
Breaking Medicine Technology:Avantium Appoints Gunnar Staaf as CEO Pharma 2AARP Illinois Key Vote News Alert 2Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit 2Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 1Optimization and Scale up of a Hydrodynamically Limited Anti Solvent Crystallization Process 3A From Lab to Plant 13541 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 1TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 2TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 3TrueVision Teams with Ophthalmologists to Help Cure World Blindness for Treatable Cataracts Debut of 3D Training Video for Manual Small Incision C 54393 4Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 1Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 2Medco Health Solutions United Drug Announce U K Homecare Pharmacy Joint Venture Serving Patients with Chronic and Complex Health Conditions 3B Innov 54388 3
... Product Candidate in Clinical Trials, SEATTLE, Sept. ... enrolling patients in a Phase 1/Phase 2 study ... use during,ophthalmologic surgery. At least 60 patients undergoing ... enrollment in the,study., "With the initiation of ...
... 8 FluoroPharma, Inc. announced today that,Dr. ... Advisor,will report on two preclinical studies demonstrating ... molecular imaging agents for detection,of Alzheimer,s disease ... Molecular,Imaging Congress, in Nice, France on September ...
Other Medicine Technology:Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 2FluoroPharma, Inc. to Report Preclinical Data on Alzheimer's Disease and Prostate Cancer PET Imaging Agents 3
... The Volk G-1 trabeculum provides the highest magnification ... for viewing and treating the trabecular meshwork. ... the anterior chamber angle while the central portion ... the posterior pole for signs of glaucoma and ...
... Volks Disposable SSV® Vitrectomy Lenses are a ... to enable a view of a particular region ... contact lens element weighs less than 1 gram ... with the typical shape of a human cornea. ...
... 30° Prism are designed for ... recommended for tractional retinal detachments ... retinal detachment. They can be ... other midperipheral laser applications. Direct ...
... The 30° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: